Literature DB >> 28058477

Elastofibroma of the gluteal region with a concomitant contralateral lesion: case report and review of the literature.

Luca Cevolani1, R Casadei2, D Vanel3, M Gambarotti3, D Donati2.   

Abstract

A 51-year-old man presented with elastofibroma (EF) of the gluteal region with a concomitant contralateral lesion. The patient presented with a slow growing mass of the proximal third of the right buttock and had swelling, discomfort in sitting, and right-hip pain during walking for 2 months. On MRI, a soft-tissue mass was noted between the gluteus maximus and the gluteus medius muscle. The mass showed similar signal intensity to the surrounding tissue on T1- and T2-weighted images and with linear hyperintense areas in its internal structure. At surgery, a soft, non-encapsulated, irregular, and rubber-like mass was found attached to the gluteus medius muscles. It was pathologically confirmed to be an EF. This unusual manifestation of an EF is discussed.

Entities:  

Keywords:  Elastofibroma; Magnetic resonance imaging; Ultrasound

Mesh:

Year:  2017        PMID: 28058477     DOI: 10.1007/s00256-016-2561-x

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  25 in total

1.  Bilateral elastofibroma of the thighs with concomitant subscapular lesions.

Authors:  Akifumi Nishida; Masataka Uetani; Tomoaki Okimoto; Kuniaki Hayashi; Toru Hirano
Journal:  Skeletal Radiol       Date:  2002-10-31       Impact factor: 2.199

2.  Gain of Xq detected by comparative genomic hybridization in elastofibroma.

Authors:  Jun Nishio Nishio; Hiroshi Iwasaki; Yuko Ohjimi; Masako Ishiguro; Takamasa Koga; Teruto Isayama; Masatoshi Naito; Masahiro Kikuchi
Journal:  Int J Mol Med       Date:  2002-09       Impact factor: 4.101

3.  High-resolution genome-wide analysis of chromosomal alterations in elastofibroma.

Authors:  Juan Luis García Hernández; Javier Ortiz Rodríguez-Parets; José María Valero; María Asunción Gomez Muñoz; M Rocío Benito; Jesus M Hernandez; Agustín Bullón
Journal:  Virchows Arch       Date:  2010-04-27       Impact factor: 4.064

Review 4.  Imaging study findings in elastofibroma dorsi.

Authors:  Jacques Malghem; Vincent Baudrez; Frédéric Lecouvet; Christian Lebon; Baudouin Maldague; Bruno Vande Berg
Journal:  Joint Bone Spine       Date:  2004-11       Impact factor: 4.929

Review 5.  Bilateral elastofibroma dorsi. A case report and review of the literature.

Authors:  J Kourda; A Ayadi-Kaddour; S Merai; S Hantous; K B Miled; F E Mezni
Journal:  Orthop Traumatol Surg Res       Date:  2009-07-22       Impact factor: 2.256

6.  Elastofibroma dorsi: clinicopathological analysis of 71 cases.

Authors:  F Lococo; A Cesario; F Mattei; G Petrone; L M Vita; L Petracca-Ciavarella; S Margaritora; P Granone
Journal:  Thorac Cardiovasc Surg       Date:  2013-01-23       Impact factor: 1.827

7.  Histogenesis of unique elastinophilic fibers of elastofibroma: ultrastructural and immunohistochemical studies.

Authors:  Y Fukuda; H Miyake; Y Masuda; Y Masugi
Journal:  Hum Pathol       Date:  1987-05       Impact factor: 3.466

8.  Sensitivity and positive predictive value of magnetic resonance imaging in the diagnosis of elastofibroma dorsi: review of fourteen cases.

Authors:  Iskandar Tamimi Mariño; Pedro Sesma Solis; Almudena Pérez Lara; Javier Martinez Malo; Maria Luz Vazquez; Faleh Tamimi
Journal:  J Shoulder Elbow Surg       Date:  2012-05-18       Impact factor: 3.019

9.  Elastofibroma oculi.

Authors:  P Austin; F A Jakobiec; T Iwamoto; A Hornblass
Journal:  Arch Ophthalmol       Date:  1983-10

10.  Elastofibroma dorsi: diagnostic and therapeutic algorithm.

Authors:  Jun Nishio; Teruto Isayama; Hiroshi Iwasaki; Masatoshi Naito
Journal:  J Shoulder Elbow Surg       Date:  2011-04-27       Impact factor: 3.019

View more
  1 in total

1.  Concomitant bilateral elastofibroma in the infrascapular and gluteal regions: a report of a rare case.

Authors:  Omran Al Dandan; Ali Hassan; Mona Al Muhaish; Jumanah AlMatrouk; Haidar Almuhanna; Tarek Hegazi
Journal:  BMC Musculoskelet Disord       Date:  2020-01-08       Impact factor: 2.362

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.